Flagship Pioneering’s new venture is betting on tRNA to treat “thousands of diseases” – TechCrunch
On Tuesday, Flagship Pioneering, the major investor behind Moderna, announced yet another addition to their portfolio of RNA-curious companies. Following a year of hype around mRNA, a new company, called Alltrna, will now focus on developing medicines based on Transfer RNA or tRNA. At this point, you’re likely familiar with the idea that messenger RNA…